Earnings Summary

Takeda Pharmaceutical Company Limited’s revenue jumped 8.86% since last year same period to $1058618Mn in the Q2 2023. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 10.72% jump in its revenue since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit fell -14.87% since last year same period to $89395Mn in the Q2 2023. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 187.13% jump in its net profits since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit margin fell -21.8% since last year same period to 8.44% in the Q2 2023. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 159.34% jump in its net profit margins since last 3-months.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a -27.06% fall from last quarter’s estimates.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.17.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Takeda Pharmaceutical Company Limited has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.